Biochemistry
Therapeutic Drug Monitoring Tests in Dubai & UAE
Investigations in this area, with the specimen type, turnaround time and listed price for each option β so you and your clinician can compare before you book.
- Quality-controlled laboratory
- Home collection across the UAE
- Confidential handling of results
Compare options
Therapeutic Drug Monitoring investigations
All 40 investigations in this category are listed below.
| Test | What it measures | Specimen | Turnaround | Price | Book |
|---|---|---|---|---|---|
| Amikacin Therapeutic Drug Monitoring Test TEST-172 LOINC 3392-1 | This test measures the concentration of amikacin in the blood to guide dosing adjustments. | Serum | 2β3 weeks | 2,000.00 AED | Details |
| Amitriptyline Test TEST-207 LOINC 3471-2 | This test measures the concentration of amitriptyline and its active metabolite nortriptyline in the serum. | Serum | 2β3 weeks (specimens received by the 7th of the month) | 2,000.00 AED | Details |
| Bromide Total Test TEST-458 LOINC 14314-1 | This diagnostic test evaluates the concentration of bromide in the patient's serum. | Serum | 3β4 weeks (batch tested) | 1,900.00 AED | Details |
| Bupropion Test TEST-460 LOINC 3530-0 | This test quantifies bupropion and hydroxybupropion levels in serum to guide therapeutic drug monitoring. | Serum | 2β3 weeks | 2,500.00 AED | Details |
| Carbamazepine Free Test TEST-544 LOINC 3533-7 | This test measures the unbound, pharmacologically active concentration of carbamazepine in serum. | Serum | 2β3 weeks | 1,500.00 AED | Details |
| Clomipramine (Anafranil) Therapeutic Drug Monitoring Test TEST-665 LOINC 3530-0 | This diagnostic test evaluates the concentration of clomipramine in the patient's serum. It aids in assessing medication efficacy and potential toxici... | Serum | 2-3 weeks (monthly batch; cut-off 7th of month) | 1,800.00 AED | Details |
| Clonazepam Test TEST-669 LOINC 4011-2 | This test measures the concentration of clonazepam in the serum to monitor therapeutic levels and guide dosage adjustments. | Serum | 2-3 weeks (sample cut-off: 7th of each month) | 1,800.00 AED | Details |
| Clorazepate Test TEST-673 LOINC 39437-5 | This diagnostic test quantifies the concentration of clorazepate and its active metabolite nordazepam in serum. | Serum | 2β3 weeks | 2,200.00 AED | Details |
| Clozapine Therapeutic Drug Monitoring Test TEST-676 LOINC 3585-4 | This test quantitatively measures serum concentrations of clozapine and its active metabolite norclozapine. | Serum | 2β3 weeks (sample must arrive by the 7th of the month) | 1,800.00 AED | Details |
| Cyclosporine A Test TEST-921 LOINC 10020-6 | This test measures the concentration of Cyclosporine A in whole blood to guide immunosuppressive therapy. | Whole blood | Same day (sample received by 5 PM); STAT within 4 hours | 550.00 AED | Details |
| Desipramine Therapeutic Drug Monitoring Test TEST-972 LOINC 3538-0 | This test measures the concentration of desipramine in the patient's serum to guide dosage adjustments. | Serum (Red Top, No Additive) | 2β3 weeks (scheduled batch processing) | 1,300.00 AED | Details |
| Dexamethasone Therapeutic Drug Monitoring Test TEST-988 LOINC 19633-6 | This test measures the concentration of dexamethasone in the blood serum to guide therapeutic dosing. | Serum | 2β3 weeks | 1,800.00 AED | Details |
| Diazepam Blood Level Test (TDM) TEST-1003 LOINC 3948-7 | This diagnostic test evaluates the concentration of diazepam and its metabolites in the patient's serum or plasma. | Peripheral Serum or Plasma | 2β3 weeks | 2,000.00 AED | Details |
| Digitoxin Test (Therapeutic Drug Monitoring) TEST-993 LOINC 3352-0 | This test measures the concentration of digitoxin in the blood serum to monitor therapeutic levels and prevent toxicity. | Serum | 2-3 weeks | 2,600.00 AED | Details |
| Disopyramide Drug Level Monitoring Test TEST-1015 LOINC 3395-7 | This diagnostic test evaluates the serum concentration of disopyramide to guide therapeutic dosing. | Serum | 2β3 weeks after sample receipt by the 7th of the month | 1,800.00 AED | Details |
| Doxepin Test TEST-1024 LOINC 3396-2 | This diagnostic test evaluates the concentration of doxepin in the patient's serum. | Serum | 3β5 Business Days | 1,500.00 AED | Details |
| Ethosuximide Test TEST-1078 LOINC 3474-6 | This test measures the concentration of ethosuximide in the serum to ensure therapeutic levels for seizure control while minimizing toxicity. | Serum | 2β3 weeks (sample must be received by the 7th of the month) | 1,800.00 AED | Details |
| Everolimus Blood Test (Therapeutic Drug Monitoring) TEST-1079 LOINC 41690-2 | This diagnostic test evaluates the concentration of everolimus in whole blood to optimize therapeutic dosing. | Whole Blood (EDTA) | 24 to 48 hours | 800.00 AED | Details |
| Felbamate Test TEST-1109 LOINC 3586-2 | This diagnostic test quantifies serum felbamate levels to guide therapeutic drug monitoring in epilepsy patients. | Serum | 2β3 weeks (batch processing) | 1,500.00 AED | Details |
| Fluoxetine Blood Test TEST-1245 LOINC 3573-1 | This diagnostic test evaluates the concentration of fluoxetine and its active metabolite, norfluoxetine, in the patient's serum. | Serum | 2β3 weeks | 2,200.00 AED | Details |
| Gabapentin Test TEST-1285 LOINC 3531-4 | This diagnostic test evaluates the concentration of gabapentin in serum or plasma to guide therapeutic drug monitoring. | Serum or Plasma (peripheral whole blood) | 5β7 business days from sample receipt | 1,500.00 AED | Details |
| HALOPERIDOL Therapeutic Drug Monitoring Test TEST-1369 LOINC 3543-8 | This diagnostic test evaluates the serum concentration of haloperidol to optimize therapeutic dosing and monitor for potential toxicity. | Serum | 2β3 weeks | 1,800.00 AED | Details |
| Immunosuppressant Drug Profile 2 Test TEST-2230 LOINC 72787-7 | This test measures the trough concentrations of four key immunosuppressant drugs (tacrolimus, cyclosporine, sirolimus, everolimus) in the blood. | Peripheral whole blood (EDTA) | Same day (sample by 5 PM) | 1,500.00 AED | Details |
| Immunosuppressant Drug Profile 3 (ISP3) Test TEST-2257 LOINC 101658-9 | This test measures the concentration of specific immunosuppressant drugs in the blood. | Peripheral Whole Blood (EDTA) | Same-day report (sample by 5 pm) | 1,500.00 AED | Details |
| Infliximab (AntiβTNF) Trough Level Test TEST-2277 LOINC 34107-0 | This diagnostic test evaluates the serum concentration of infliximab, a TNF-Ξ± blocker, at the trough level before the next infusion. | Serum (peripheral blood) | 2β3 weeks from sample receipt (sample must arrive by the 7th of the month) | 4,000.00 AED | Details |
| Lamotrigine (Lamictal) Therapeutic Drug Monitoring (TDM) Test TEST-2341 LOINC 11444-9 | This diagnostic test evaluates the concentration of lamotrigine in the patient's serum. | Serum | 2β3 weeks | 1,500.00 AED | Details |
| Levetiracetam Therapeutic Drug Monitoring (TDM) Test TEST-2405 LOINC 29631-0 | This test measures the concentration of levetiracetam in the serum to guide epilepsy treatment. | Serum | 14β21 working days | 2,200.00 AED | Details |
| Mesoridazine Therapeutic Drug Monitoring Test TEST-2516 LOINC 39479-6 | This test measures the concentration of mesoridazine in the patient's serum to guide therapeutic dosing. | Serum | 2β3 weeks (sample must arrive by 7th of month) | 1,800.00 AED | Details |
| Mitotane Therapeutic Drug Monitoring Test TEST-2569 LOINC 13980-1 | This diagnostic test evaluates the concentration of mitotane in a patient's serum. | Serum (peripheral whole blood) | 2β3 weeks | 2,500.00 AED | Details |
| Nortriptyline Test TEST-2678 LOINC 2074-0 | This diagnostic test evaluates the concentration of nortriptyline in the patient's serum. | Serum | 2β3 weeks (batchβoptimised) | 1,800.00 AED | Details |
| Oxcarbazepine Metabolite Test TEST-2850 LOINC 35368-2 | This test measures the concentration of 10-hydroxycarbazepine (MHD), the active metabolite of oxcarbazepine, in a blood sample. | Peripheral Blood (Serum/Plasma) | 10 Working Days (MonβSat processing) | 1,000.00 AED | Details |
| Paroxetine Test (Therapeutic Drug Monitoring) TEST-2864 LOINC 34891-4 | This test measures the concentration of paroxetine in the patient's serum to optimize therapeutic dosing and monitor for potential toxicity. | Serum | 2β3 weeks | 4,500.00 AED | Details |
| Procainamide and N-Acetylprocainamide (NAPA) Test TEST-2953 LOINC 3528-7 | This test measures the concentration of the antiarrhythmic drug procainamide and its active metabolite NAPA in the blood. | Serum | 2β3 Weeks | 2,500.00 AED | Details |
| Sirolimus (Rapamycin) Test TEST-3134 LOINC 3395-0 | This test measures the concentration of sirolimus (rapamycin) in whole blood to guide immunosuppressive therapy. | Whole Blood (EDTA) | Same-day reporting when sample arrives by 5 PM | 900.00 AED | Details |
| Tacrolimus (FK506) Therapeutic Drug Monitoring Test TEST-3225 LOINC 3991-7 | This test measures the concentration of tacrolimus (FK506) in whole blood to guide immunosuppressive therapy in transplant patients. | Whole blood (EDTA) | Same-day (sample received by 5 PM) | 750.00 AED | Details |
| Thioridazine Test TEST-3272 LOINC 3948-1 | This diagnostic test evaluates the concentration of thioridazine in the patient's serum. | Blood (Serum) | 14β21 days | 1,900.00 AED | Details |
| Topiramate Test TEST-3301 LOINC 10375-9 | This diagnostic test evaluates the concentration of topiramate in a patient's serum or plasma. | Serum or Plasma | 3β5 business days | 1,800.00 AED | Details |
| Trazodone Therapeutic Drug Monitoring Test TEST-3311 LOINC 35729-1 | This test measures the concentration of trazodone in the blood to help optimize dosage and monitor for potential toxicity. | Serum | 2β3 weeks (after monthly batch cutoff) | 1,500.00 AED | Details |
| Trimipramine Therapeutic Drug Monitoring Test TEST-3337 LOINC 3949-0 | This diagnostic test evaluates the concentration of trimipramine in the patient's serum to guide safe and effective dosing. | Serum | 2β3 weeks | 1,800.00 AED | Details |
| Vancomycin Test (Therapeutic Drug Monitoring) TEST-3373 LOINC 4103-0 | This test measures the lowest concentration of vancomycin in the blood just before the next dose (trough level). It helps optimize dosing to ensure ef... | Serum | Same Day (sample received by 4 PM) | 900.00 AED | Details |
Clinical overview
About Therapeutic Drug Monitoring
Before your appointment
Preparation & sample collection
Follow the instructions you are given
Fasting, timing and medicine restrictions differ between investigations. The instructions for your specific request are confirmed when you book.
Bring your identification
A valid photo ID is required at collection so that your sample is matched correctly to your record.
Tell us about medicines
Prescription medicines, supplements and recent procedures can affect how an investigation is scheduled or interpreted β please mention them.
Ask before collection
If anything about preparation is unclear, contact us before your appointment. Preparation errors can affect reporting times.
Patient information
Frequently asked questions
Practical answers about Therapeutic Drug Monitoring testing at DNA Labs UAE. This information is general and does not replace advice from your treating clinician.
How do I choose the right Therapeutic Drug Monitoring test?
The correct investigation depends on what your clinician is trying to establish. Review the specimen type and turnaround time below, then confirm the choice with your treating doctor before booking.
What specimen is required?
Specimen requirements are listed for each investigation. If a request involves more than one sample type, our team will confirm what is needed at the time of booking.
Do you offer home sample collection in Dubai and the UAE?
Yes. Home collection can be arranged across Dubai and the wider UAE. Availability and appointment windows vary by location, so please confirm when you book.
How long do results take?
Turnaround depends on the investigation and the method used. The expected reporting time is confirmed with you before collection.
Is there anything I need to do before sample collection?
Some investigations require fasting, a specific collection time, or avoiding certain medicines or activities. Preparation details are shared when you book β please follow them and ask if anything is unclear.
How will I receive my report?
Reports are issued as secure digital documents and can be shared with your referring clinician on request. Please review results with a qualified clinician who can interpret them in context.
About this clinical information
The information on this Therapeutic Drug Monitoring page describes laboratory investigations in general terms. It is written to help you understand what an investigation involves β it is not a diagnosis and it is not a substitute for advice from your treating clinician.
- Investigation names, specimen types and listed prices are reviewed against laboratory records.
- Preparation guidance is indicative β confirm test-specific instructions before collection.
- Content is updated when investigations, methods or reporting formats change.
- Results are released to the patient and, on request, shared with the referring clinician.
Medical disclaimer: This page is for general information and education only. It is not medical advice, diagnosis or treatment, and it does not replace a consultation with a qualified healthcare professional. Always seek the advice of your doctor or another qualified provider with any questions about a medical condition or before ordering a test.
We're here to help
Need help choosing a Therapeutic Drug Monitoring test?
Tell us what your clinician has requested and we'll confirm availability, price, preparation and the most convenient collection option β including home collection in Dubai and across the UAE.
- Home collection available across the UAE
- Digital reports delivered securely
- Confidential handling of every request
Related areas